WEEKLY E-NEWS FROM THE NORTH CAROLINA BIOTECHNOLOGY CENTER

IN FOCUS FEATURE

First Tenants Picked for Triad Wet Lab Incubator

From Our Web Site

TransTech Pharma and PharmaCore to Create 205 Jobs
TransTech Pharma, a clinical pharmaceutical development company, and PharmaCore, a sister company, will expand in High Point and create 205 jobs during the next five years, state and local officials said.

Carbonell to Lead Biomanufacturing Training and Education Center
North Carolina State University Professor Ruben Carbonell will direct the Golden LEAF Biomanufacturing Training and Education Center starting Jan. 1.

Cempra Closes on $10M Venture Investment
Cempra Pharmaceuticals, a Morrisville-based developer of anti-infectives, has raised $10 million in new Series B funding to bolster its previous $24 million from venture investors.

Wyeth Recognized for Employee Protection Efforts
The North Carolina Department of Labor recognized Wyeth's employee safety efforts at the company's Sanford vaccine manufacturing and research facility and the research facility in Research Triangle Park.

In Focus

First Tenants Picked for Triad Wet Lab Incubator

Tengion and Carolina Liquid Chemistries were heralded Dec. 17 as the first tenants chosen to occupy the much-anticipated Piedmont Triad Research Park Wet Lab LaunchPad project in downtown Winston-Salem.

Tengion, a tissue-engineering company associated with the Wake Forest University Institute for Regenerative Medicine, and Carolina Liquid, a Brea, Calif., biotech start-up developing diagnostic products, were applauded for their pioneering role during a grand opening gala featuring facility tours, speeches and a celebration of the coalition involving 31 partners that made it all possible.

Read the full article.

News from Other Sites

UNC Commits More Than $200 Million to Pursue 'Must-Have' Grant
"The National Institutes of Health will bestow Clinical and Translational Science Awards to 60 academic medical centers around the country by 2012. The purpose of the awards is to promote the transfer of medical research from the university into the community."
From The Triangle Business Journal

Phase BioScience on Hunt for $2.15 Million
"Phase BioScience is seeking an extra $2.15 million in series B venture capital after closing on a $6.6 million round earlier this year, according to filings with the North Carolina Department of the Secretary of State."
From The Triangle Business Journal

Community Watch

• Qualyst, a Raleigh-based bioproducts developer, has licensed its B-CLEAR system of products and services for European sales to Solvo, Hungary.
• RTI International has promoted Susana Perez-Gutthann, M.D., M.P.H., Ph.D., FISPE, FRCP, to vice president and global head of epidemiology of its RTI Health Solutions business unit, which provides research and consulting services to pharmaceutical clients.

Please send Community Watch items to Jim Shamp.

Announcements

• Happy Holidays.
• BT Catalyst will not be published Dec. 27, 2007.

---

This newsletter was sent Thursday, Dec. 20, 2007. For the latest North Carolina biotechnology industry headlines, please visit the news section of our Web site.

Online subscription management is now available. Please respond to this e-mail if you cannot change your preferences online.